In conclusion, HDAC inhibition increases PD-L1 and HLA-DR expression in TNBC and decreases Treg frequency, which when combined with PD-1 and CTLA-4 blockade promotes TILs infiltration, tumor apoptosis, tumor regression and increased survival in mice (Figure 7). The gene discussed is HDAC9; the disease is neoplasm.